Welcome to LookChem.com Sign In|Join Free
  • or
2-(Benzyloxy)acetamide, with the molecular formula C9H11NO2, is an amide derivative of 2-(benzyloxy)acetic acid. It is a white to off-white solid that is soluble in alcohol and ether, and has a molecular weight of 165.19 g/mol. 2-(benzyloxy)acetamide is commonly used in organic synthesis as a building block for creating various biologically active compounds due to its ability to be modified into different functional groups, making it a versatile intermediate in the synthesis of new chemical compounds.

5774-77-6

Post Buying Request

5774-77-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5774-77-6 Usage

Uses

Used in Pharmaceutical Industry:
2-(Benzyloxy)acetamide is used as a synthetic intermediate for the development of various pharmaceutical compounds. Its versatility in being modified into different functional groups allows for the creation of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
2-(Benzyloxy)acetamide is used as a building block in the synthesis of agrochemicals, such as pesticides and herbicides. Its ability to be modified into various functional groups enables the development of new agrochemicals with improved efficacy and selectivity.

Check Digit Verification of cas no

The CAS Registry Mumber 5774-77-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,7,7 and 4 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 5774-77:
(6*5)+(5*7)+(4*7)+(3*4)+(2*7)+(1*7)=126
126 % 10 = 6
So 5774-77-6 is a valid CAS Registry Number.

5774-77-6Relevant academic research and scientific papers

[6,6] FUSED BICYCLIC HDAC8 INHIBITORS

-

Paragraph 00373, (2019/08/15)

The present invention is directed to compounds of Formula I: and pharmaceutically acceptable salts, prodrugs, solvates, hydrates, tautomers, or isomers or thereof, wherein R1, R2, R2', L, X, W, Y1,Y2,

RSK INHIBITORS AND THERAPEUTIC USES THEREOF

-

Page 46-47, (2008/06/13)

The present invention is directed to novel compounds and compositions that have Rsk specific inhibitory activity. In addition, inhibition of Rsk by the present compounds has been discovered to halt the proliferation of cancer cell lines while having little effect on the proliferation rate of normal cells. Therefore, the present invention identifies Rsk as a target for therapeutic intervention in diseased states in which the disease or the symptoms can be ameliorated by inhibition of Rsk catalytic activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5774-77-6